Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FKB327-006 PK and Safety Comparison with Humira in Healthy Adults
jRCT2071200057Phase 1Completed
- Sponsor
- FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd.
- Start
- Jul 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of qletli in rheumatoid arthritis (RA) (2 arms), sponsored by FUJIFILM KYOWA KIRIN BIOLOGICS Co., Ltd. Primary endpoints: Cmax and AUC0-t. Started Jul 2017; status: completed.
02
Drugs
qletli
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on jRCT2071200057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071200057.